S E Bellomo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

S E Bellomo

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Journal of Agricultural and Food Chemistry|July 17, 2001

Storage temperature effects on blood orange fruit qualityP Rapisarda, S E Bellomo, S Intelisano

Journal of Translational Medicine|May 15, 2024

Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohortI Vanni, L Pastorino, V Andreotti, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2025

Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma GroupL D'Ambrosio, A Merlini, A Brunello, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Journal of Agricultural and Food Chemistry|July 17, 2001

Storage temperature effects on blood orange fruit qualityP Rapisarda, S E Bellomo, S Intelisano

Journal of Translational Medicine|May 15, 2024

Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohortI Vanni, L Pastorino, V Andreotti, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2025

Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma GroupL D'Ambrosio, A Merlini, A Brunello, et al.

Pageof 1